Catalytic undirected methylation of unactivated C(sp3)−H bonds suitable for complex molecules
In pharmaceutical discovery, the "magic methyl" effect describes a substantial improvement in the pharmacological properties of a drug candidate with the incorporation of methyl groups. Therefore, to expedite the synthesis of methylated drug analogs, late-stage, undirected methylations of C(sp<sup>3</sup>)-H bonds in complex molecules would be valuable. However, current methods for site-selective methylations are limited to activated C(sp<sup>3</sup>)-H bonds. Here we describe a site-selective, undirected methylation of unactivated C(sp<sup>3</sup>)-H bonds, enabled by photochemically activated peroxides and a nickel(II) complex whose turnover is enhanced by an ancillary ligand. The methodology displays compatibility with a wide range of functional groups and a high selectivity for tertiary C-H bonds, making it suitable for the late-stage methylation of complex organic compounds that contain multiple alkyl C-H bonds, such as terpene natural products, peptides, and active pharmaceutical ingredients. Overall, this method provides a synthetic tool to explore the "magic methyl" effect in drug discovery.
Authors
- Yi Cheng Kang (ORCID: https://orcid.org/0000-0002-1171-2404)
- Jin-Fay Tan (ORCID: https://orcid.org/0000-0002-1121-7630)
- John F. Hartwig (ORCID: https://orcid.org/0000-0002-4157-468X)
Institutions
- University of California, Berkeley (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1038/s41467-024-52245-1
- Citations
- 7
- Primary Topic
- Catalytic C–H Functionalization Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.75
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- National Institute of General Medical Sciences